Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Manu Sondhi"'
Autor:
Connie Lee Batlevi, Gilles Salles, Steven I. Park, Tycel J. Phillips, Jennifer E. Amengual, David Andorsky, Philip Campbell, Pamela McKay, John P. Leonard, Manu Sondhi, Yingxue Chen, Pamela L. Slatcher, Richard Lin, Attila Szanto, Sara Abbadi, Franck Morschhauser
Publikováno v:
Blood. 140:2296-2298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9bb806d4a47d46092300b48904c2167
https://doi.org/10.1182/blood-2022-166991
https://doi.org/10.1182/blood-2022-166991
Autor:
Connie Lee Batlevi, Steven I. Park, Tycel Jovelle Phillips, Jennifer Amengual, David Jacob Andorsky, Philip Campbell, Pamela McKay, John Paul Leonard, Manu Sondhi, Jay Yang, Yingxue Chen, Heather O'Connor, Pamela Slatcher, Franck Morschhauser
Publikováno v:
Journal of Clinical Oncology. 40:7572-7572
7572 Background: Tazemetostat (TAZ), an enhancer of zeste homolog 2 (EZH2) inhibitor, showed antitumor activity as monotherapy in patients with relapsed or refractory (R/R) follicular lymphoma (FL) who received ≥2 prior lines of therapy. In clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a20104ec48c78e30ac9d77cca44563
https://doi.org/10.1200/jco.2022.40.16_suppl.7572
https://doi.org/10.1200/jco.2022.40.16_suppl.7572
Autor:
Giulia Val Bianchi, Xavier Pivot, Guy Jerusalem, Luis de la Cruz-Merino, Stephen Chia, Tetiana Taran, Gabe S. Sonke, Seock-Ah Im, Arnd Nusch, Francisco J. Esteva, Patrick Neven, J. Thaddeus Beck, Michelino De Laurentiis, Miguel Martin, Arunava Chakravartty, Dennis J. Slamon, K. Petrakova, Yingbo Wang, Karen Rodriguez-Lorenc, Manu Sondhi, Peter A. Fasching
In an earlier analysis of this phase 3 trial, ribociclib plus fulvestrant showed a greater benefit with regard to progression-free survival than fulvestrant alone in postmenopausal patients with hormone-receptor-positive, human epidermal growth facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba7b985d7c2eab2c811a010405df43e
http://hdl.handle.net/11588/804127
http://hdl.handle.net/11588/804127
Autor:
Peter A. Fasching, Brad Lanoue, Karen Rodriguez-Lorenc, Patrick Neven, G. Jerusalem, A. Gaur, Manu Sondhi, Arnd Nusch, M. Martin Jimenez, Giancarlo Bianchi, M. De Laurentiis, A. Chan, David Chandiwana, JT Beck, S Chia
Publikováno v:
Annals of Oncology. 31:S67-S68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5241dbbd8e559794022891dde731117
https://doi.org/10.1016/j.annonc.2020.03.245
https://doi.org/10.1016/j.annonc.2020.03.245
Autor:
Keqin Qi, Yousef Zakharia, Robert Huddart, Se Hoon Park, Scott T. Tagawa, Yohann Loriot, Andrea Necchi, Monika Joshi, Jesús García-Donas, Manish Monga, Earle F. Burgess, Anne OHagan, Begoña Mellado, Arash Rezazadeh, Arlene O. Siefker-Radtke, Manu Sondhi, Ignacio Duran, Mark D. Fleming, Sergei Varlamov
Publikováno v:
Journal of Clinical Oncology. 39:426-426
426 Background: Erdafitinib (ERDA), a pan-FGFR kinase inhibitor, was US FDA approved for adults with mUC with susceptible FGFR3/2 alterations ( FGFRa) who progressed on ≥ 1 line of prior platinum-based chemotherapy based on primary results of the B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f324f90f013ea7f85fa8977552d22ad3
https://doi.org/10.1200/jco.2021.39.6_suppl.426
https://doi.org/10.1200/jco.2021.39.6_suppl.426
Autor:
Denise A. Yardley, Dennis J. Slamon, Thomas Bachelot, Agnes Lteif, Arnd Nusch, Karen Rodriguez-Lorenc, Gabe S. Sonke, Paul Wheatley-Price, Patrick Neven, Stephen Chia, A. Gaur, Manu Sondhi, Yoon Sim Yap, Arlene Chan
Publikováno v:
Journal of Clinical Oncology. 38:1054-1054
1054 Background: In the Phase III ML-3 (NCT02422615) and ML-7 (NCT02278120) trials, RIB + ET demonstrated a significant OS benefit (ML-3: HR, 0.72, P = 0.00455; ML-7: HR, 0.71, P = 0.00973) over placebo (PBO) + ET in pts with HR+/HER2- ABC (Im et al.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a037608ef4e8a83c7436db06df9091c7
https://doi.org/10.1200/jco.2020.38.15_suppl.1054
https://doi.org/10.1200/jco.2020.38.15_suppl.1054
Autor:
JT Beck, Xavier Pivot, Arnd Nusch, L. De la Cruz-Merino, Gabe S. Sonke, Patrick Neven, Manu Sondhi, Karen Rodriguez-Lorenc, K. Petrakova, Peter A. Fasching, S Chia, Francisco J. Esteva, DJ Slamon, M. Martin, G. Jerusalem, S.-A. Im, Giancarlo Bianchi, Yirong Wang, Arunava Chakravartty, M. De Laurentiis
Publikováno v:
Annals of Oncology. 30:v856-v857
Background The phase III MONALEESA-3 trial (NCT02422615; N = 726) investigated RIB, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, + FUL as first-line (1L) or second-line (2L) treatment for postmenopausal pts with HR+/HER2− ABC. Here we report O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d2c988298c0c6cd836dd895b391a5ec
https://doi.org/10.1093/annonc/mdz394.007
https://doi.org/10.1093/annonc/mdz394.007
Autor:
Timothy P. Hughes, Andreas Hochhaus, Massimo Breccia, Philipp le Coutre, Gabriel Etienne, Moshe Talpaz, Hironobu Minami, Kaushal Mishra, Fabian Lang, Jorge E. Cortes, Daniel J. DeAngelo, Dong-Wook Kim, Yeow Tee Goh, Michael W. Deininger, Delphine Rea, Manu Sondhi, Michael J. Mauro, Paola Aimone
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S289-S290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3376f826349e1c3e3b1f2f3a80ced94b
https://doi.org/10.1016/j.clml.2019.07.234
https://doi.org/10.1016/j.clml.2019.07.234
Autor:
Andreas Hochhaus, Fabian Lang, Paola Aimone, Philipp le Coutre, Timothy P. Hughes, Dong-Wook Kim, Manu Sondhi, Massimo Breccia, Yeow Tee Goh, Daniel J. DeAngelo, Hironobu Minami, Gary J. Vanasse, Jorge E. Cortes, Florence Hourcade-Potelleret, Michael J. Mauro, Kaushal Mishra, Moshe Talpaz, Delphine Rea
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S290-S291
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4941994e7971e27a8c7c4b9b7a8ee042
https://doi.org/10.1016/j.clml.2019.07.236
https://doi.org/10.1016/j.clml.2019.07.236
Autor:
Kaushal Mishra, Daniel J. DeAngelo, Timothy P. Hughes, Delphine Rea, Florence Hourcade-Potelleret, Moshe Talpaz, Dong-Wook Kim, Yeow Tee Goh, Michael J. Mauro, Gary J. Vanasse, Jorge E. Cortes, Philipp le Coutre, Paola Aimone, Hironobu Minami, Fabian Lang, Massimo Breccia, Andreas Hochhaus, Manu Sondhi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S287-S288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::262107d4c5b7e94fa8583eb43d8951ff
https://doi.org/10.1016/j.clml.2019.07.231
https://doi.org/10.1016/j.clml.2019.07.231